|
NUDT5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.31360000000547E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.155690E-04 |
| Normal-vs-Stage2 |
3.891700E-02 |
| Normal-vs-Stage3 |
2.341700E-02 |
| Normal-vs-Stage4 |
5.418800E-03 |
| Stage1-vs-Stage2 |
7.996400E-01 |
| Stage1-vs-Stage3 |
4.810600E-01 |
| Stage1-vs-Stage4 |
8.845400E-01 |
| Stage2-vs-Stage3 |
4.974200E-01 |
| Stage2-vs-Stage4 |
7.511400E-01 |
| Stage3-vs-Stage4 |
6.466600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.817000E-04 |
| Normal-vs-AfricanAmerican |
6.424500E-03 |
| Normal-vs-Asian |
2.803900E-02 |
| Caucasian-vs-AfricanAmerican |
3.278200E-01 |
| Caucasian-vs-Asian |
8.159400E-01 |
| AfricanAmerican-vs-Asian |
3.098600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.439690E-02 |
| Normal-vs-Female |
3.69980000000103E-05 |
| Male-vs-Female |
4.019400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.203520E-03 |
| Normal-vs-Age(41-60Yrs) |
1.083920E-02 |
| Normal-vs-Age(61-80Yrs) |
1.801300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.286300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.074400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.310600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.451200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.624630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.382600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.122600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.458600E-01 |
| Classical-VS-Follicular |
1.597520E-03 |
| Classical-VS-Other |
4.965600E-01 |
| Classical-VS-Normal |
7.041100E-03 |
| Tall-VS-Follicular |
1.395770E-02 |
| Tall-VS-Other |
5.630400E-01 |
| Tall-VS-Normal |
7.540300E-02 |
| Follicular-VS-Other |
5.474000E-01 |
| Follicular-VS-Normal |
2.01719999999295E-05 |
| Other-VS-Normal |
2.435400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.85800000000503E-05 |
| Normal-vs-N1 |
1.605810E-02 |
| N0-vs-N1 |
9.540000E-01 |
|
|
